​

CVS Health (CVS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CVS Stock Forecast

CVS Health (CVS) stock forecast, based on 40 Wall Street analysts, predicts a 12-month average price target of $70.50, with a high of $77.00 and a low of $66.00. This represents a 2.84% increase from the last price of $68.55.

$40 $48 $56 $64 $72 $80 High: $77 Avg: $70.5 Low: $66 Last Closed Price: $68.55

CVS Stock Rating

CVS Health stock's rating consensus is Buy, based on 40 Wall Street analysts. The breakdown includes 2 Strong Buy (5.00%), 29 Buy (72.50%), 9 Hold (22.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 40 0 9 29 2 Strong Sell Sell Hold Buy Strong Buy

CVS Price Target Upside V Benchmarks

TypeNameUpside
StockCVS Health2.84%
SectorHealthcare Stocks 33.91%
IndustryHealthcare Plans Stocks9.88%

Price Target Trends

1M3M12M
# Anlaysts-112
Avg Price Target-$77.00$71.75
Last Closing Price$68.55$68.55$68.55
Upside/Downside-12.33%4.67%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 257129--28
Mar, 257138--28
Feb, 2561110--27
Jan, 2561210--28
Dec, 2461211--29
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 18, 2025Argus Research$77.00$65.5717.43%12.33%
Dec 03, 2024George HillDeutsche Bank$66.00$59.0811.71%-3.72%
Nov 18, 2024Stephen BaxterWells Fargo$66.00$57.1115.57%-3.72%
Oct 24, 2024Ann HynesMizuho Securities$66.00$57.0415.71%-3.72%
Oct 21, 2024David MacDonaldTruist Financial$76.00$58.2030.58%10.87%
Oct 21, 2024Jessica TassanPiper Sandler$72.00$59.1521.72%5.03%
Oct 10, 2024Andrew MokBarclays$82.00$66.6323.07%19.62%
Aug 08, 2024George HillDeutsche Bank$63.00$57.858.90%-8.10%
Jun 28, 2024Lisa GillJ.P. Morgan$86.00$58.5846.81%25.46%
Jun 28, 2024Brian AbrahamsRBC Capital$74.00$58.5826.32%7.95%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 15, 2025Morgan StanleyOverweightOverweighthold
Jan 30, 2025Edward JonesBuyupgrade
Dec 20, 2024Cowen & Co.BuyBuyhold
Nov 18, 2024Wells FargoBuyOverweightupgrade
Oct 23, 2024RBC CapitalUnderperformUnderperformhold
Oct 21, 2024Piper SandlerOverweightOverweighthold
Oct 11, 2024Cowen & Co.BuyBuyhold
Oct 10, 2024BarclaysEqual-WeightOverweightupgrade
Oct 08, 2024Evercore ISIOutperformOutperformhold
Oct 04, 2024Cowen & Co.HoldBuyupgrade

Financial Forecast

EPS Forecast

$3 $4 $5 $6 $7 $8 $9 $10 $11 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.48$6.00$3.29$6.49$3.66----
Avg Forecast$7.44$8.25$8.63$8.61$5.15$5.87$6.88$8.19$10.15
High Forecast$7.60$8.43$8.95$8.64$5.81$7.03$8.43$8.98$10.69
Low Forecast$7.29$8.09$8.32$8.59$4.65$5.34$5.83$7.49$9.66
Surprise %-26.34%-27.27%-61.88%-24.62%-28.93%----

Revenue Forecast

$250B $300B $350B $400B $450B $500B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$268.71B$292.11B$322.47B$357.78B$372.81B----
Avg Forecast$267.95B$290.59B$315.12B$354.36B$371.88B$385.40B$405.34B$421.93B$443.77B
High Forecast$272.43B$295.45B$324.21B$356.91B$373.69B$401.00B$405.76B$424.16B$461.94B
Low Forecast$263.76B$286.05B$306.42B$351.62B$367.69B$372.45B$404.92B$419.69B$427.19B
Surprise %0.28%0.52%2.33%0.96%0.25%----

Net Income Forecast

$4B $6B $8B $10B $12B $14B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$7.18B$8.00B$4.31B$8.34B$4.61B----
Avg Forecast$5.39B$6.83B$7.85B$8.34B$6.75B$7.97B$9.20B$10.62B$13.09B
High Forecast$6.47B$8.19B$9.42B$10.01B$7.50B$9.06B$10.88B$11.58B$13.79B
Low Forecast$4.31B$5.46B$6.28B$6.68B$6.00B$6.88B$7.52B$9.66B$12.46B
Surprise %33.22%17.17%-45.10%--31.65%----

CVS Forecast FAQ

Is CVS Health stock a buy?

CVS Health stock has a consensus rating of Buy, based on 40 Wall Street analysts. The rating breakdown includes 2 Strong Buy, 29 Buy, 9 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CVS Health is a favorable investment for most analysts.

What is CVS Health's price target?

CVS Health's price target, set by 40 Wall Street analysts, averages $70.5 over the next 12 months. The price target range spans from $66 at the low end to $77 at the high end, suggesting a potential 2.84% change from the previous closing price of $68.55.

How does CVS Health stock forecast compare to its benchmarks?

CVS Health's stock forecast shows a 2.84% upside, underperforming the average forecast for the healthcare stocks sector (33.91%) and underperforming the healthcare plans stocks industry (9.88%).

What is the breakdown of analyst ratings for CVS Health over the past three months?

  • April 2025: 25.00% Strong Buy, 42.86% Buy, 32.14% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 25.00% Strong Buy, 46.43% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 22.22% Strong Buy, 40.74% Buy, 37.04% Hold, 0% Sell, 0% Strong Sell.

What is CVS Health’s EPS forecast?

CVS Health's average annual EPS forecast for its fiscal year ending in December 2025 is $5.87, marking a 60.38% increase from the reported $3.66 in 2024. Estimates for the following years are $6.88 in 2026, $8.19 in 2027, and $10.15 in 2028.

What is CVS Health’s revenue forecast?

CVS Health's average annual revenue forecast for its fiscal year ending in December 2025 is $385.4B, reflecting a 3.38% increase from the reported $372.81B in 2024. The forecast for 2026 is $405.34B, followed by $421.93B for 2027, and $443.77B for 2028.

What is CVS Health’s net income forecast?

CVS Health's net income forecast for the fiscal year ending in December 2025 stands at $7.97B, representing an 72.83% increase from the reported $4.61B in 2024. Projections indicate $9.2B in 2026, $10.62B in 2027, and $13.09B in 2028.